UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $218,000 | -6.8% | 3,041 | -53.7% | 0.01% | +20.0% |
| Q3 2018 | $234,000 | -90.2% | 6,564 | -89.6% | 0.01% | -89.1% |
| Q2 2018 | $2,382,000 | +251.3% | 63,181 | +119.1% | 0.05% | +228.6% |
| Q1 2018 | $678,000 | -50.8% | 28,838 | -58.5% | 0.01% | -53.3% |
| Q4 2017 | $1,379,000 | +245.6% | 69,496 | +67.3% | 0.03% | +275.0% |
| Q3 2017 | $399,000 | +299.0% | 41,543 | +140.6% | 0.01% | +300.0% |
| Q1 2017 | $100,000 | – | 17,264 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |